John Collins

Clayton Utz
Partner Sydney

He is truly exceptional, offering pragmatic and prompt advice. He has secured major victories for his clients and is definitely one of the leading lights in Australian patent litigation.

– Chambers Asia Pacific


A leading litigator in the Intellectual Property & Technology space, with special expertise in international disputes in innovation-focused industries such as pharmaceuticals, biotech, medical devices, competition law, software development and telecommunications.

John is the National Practice Group Leader of the IP & Technology team.

Notable Work
  • Novartis AG: acting in proceedings to enforce for blockbuster multiple sclerosis drugs Gilenya, Entresto, Stalevo, Aclasta, Zometa.
  • Sandoz: acting in the long-running Lundbeck escitalopram (Lexapro) patent infringement litigation.
  • Fresenius Kabi: acting in proceedings against Samsung Bioepis in connection with adalimumab
  • Expert witness: acting as an expert witness on Australian patent law in US arbitral proceedings concerning Gilead’s HIV drug portfolio.
  • Merck Sharp & Dohme: acting in competition litigation against BMS concerning blockbuster Keytruda.
  • Apple: acted in connection with patent disputes against Chinese smartphone manufacturers
  • AT&T: acted in contract dispute with local technology transfer.
  • nbn, Optus and Telstra: acted in various patent and contract disputes concerning DPUs, compression and content technologies.
  • GME: acted successfully in Federal Court registered design infringement proceedings.
Find other people to support you